Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
IASLC Grading System as a Predictor for EGFR-TKI Therapy
ClinicalTrials.gov study NCT06131645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the
ClinicalTrials.gov study NCT06959108. IPD Sharing: YES. Countries: 0. Publications: 0.
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
ClinicalTrials.gov study NCT02321046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
ClinicalTrials.gov study NCT05967689. IPD Sharing: NO. Countries: 12. Publications: 0.
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.
ClinicalTrials.gov study NCT06142617. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
ClinicalTrials.gov study NCT06722911. IPD Sharing: NO. Countries: 1. Publications: 0.
Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR
ClinicalTrials.gov study NCT04785742. IPD Sharing: NO. Countries: 1. Publications: 0.
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
ClinicalTrials.gov study NCT07239102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR
ClinicalTrials.gov study NCT02178397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
ClinicalTrials.gov study NCT06863506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
ClinicalTrials.gov study NCT06604689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
ClinicalTrials.gov study NCT02342353. IPD Sharing: NO. Countries: 1. Publications: 0.
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
ClinicalTrials.gov study NCT07001995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study
ClinicalTrials.gov study NCT04397432. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients
ClinicalTrials.gov study NCT02025218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study
ClinicalTrials.gov study NCT00717002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
ClinicalTrials.gov study NCT05946460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT05360381. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
ClinicalTrials.gov study NCT03381430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05694936. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.